Kestra Medical Technologies, Ltd. is a wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington.
| Revenue (TTM) | $95.13M |
| Gross Profit (TTM) | $48.86M |
| EBITDA | $-126.03M |
| Operating Margin | -137.40% |
| Return on Equity | -56.60% |
| Return on Assets | -25.80% |
| Revenue/Share (TTM) | $1.76 |
| Book Value | $4.45 |
| Price-to-Book | 5.67 |
| Price-to-Sales (TTM) | 15.73 |
| EV/Revenue | 13.91 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 66.20% |
| Shares Outstanding | $58.60M |
| Float | $32.78M |
| % Insiders | 5.30% |
| % Institutions | 103.19% |
Volatility is currently contracting
Kestra Medical Technologies, Ltd. (KMTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
KIRKLAND, Wash., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report first quarter fiscal 2027 financial results after the market closes on Monday, September 14.
KIRKLAND, Wash., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced the appointment of Curtis Kopf as Senior Vice President of Customer Experience. In this newly created role, Mr. Kopf will lead the patient experience from approval of a patient order through completion of therapy and device return, aligning the people, processes and technology that support providers and their patients throughout the use of the ASSURE® WCD.
Kestra Medical Technologies, Ltd. (KMTS) saw its shares surge in the last session with trading volume being higher than average.
Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript
KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it has entered into a five-year term loan facility with funds managed by Pharmakon Advisors, LP.
KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the fourth quarter and fiscal year ended April 30, 2026.
KIRKLAND, Wash., June 30, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report fourth quarter fiscal 2026 financial results after the market closes on Tuesday, July 14.
KIRKLAND, Wash., April 29, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
KIRKLAND, Wash., April 22, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on KMTS and any ticker you trade — then tracks every position and per-strategy win rate.
